Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-07-10
2007-07-10
Powers, Fiona T (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S613000, C548S495000, C564S191000
Reexamination Certificate
active
11594935
ABSTRACT:
Substituted cyclohexylcarboxylic acid amide compounds, processes for their production, pharmaceutical compositions containing these compounds and the use of substituted cyclohexylcarboxylic acid compounds for producing pharmaceutical compositions for treating conditions or disease states associated with the opioid receptor system and/or with noradrenalin and/or serotonin re-uptake.
REFERENCES:
patent: 7173045 (2007-02-01), Sundermann et al.
patent: 2004/0063935 (2004-04-01), Yasuda et al.
patent: 2004/0162287 (2004-08-01), Sundermann et al.
patent: 2004/0229926 (2004-11-01), Yasuda et al.
patent: 2005/0277674 (2005-12-01), Hinze et al.
patent: 1 325 910 (2003-07-01), None
patent: WO 98/25897 (1998-06-01), None
patent: WO 01/87838 (2001-11-01), None
patent: WO 02/090317 (2002-11-01), None
International Search Report dated Sep. 5, 2005 with English translation (four (4) pages).
German Search Report dated Nov. 11, 2004 with English translation of relevant portion (seven (7) pages).
Toshiya Manabe et al., “Facilitation of Long-Term Potentiation and Memory in Mice Lacking Nociceptin Receptors”, Letters To Nature, Aug. 6, 1998, pp. 577-581, vol. 394, Macmillan Publishers Ltd.
Miyuki Nishi et al., “Unrestrained Nociceptive Response and Disregulation of Hearing Ability in Mice Lacking the Nociceptin/OrphaninFQ Receptor,” The EMBO Journal, 1997, pp. 1858-1864, vol. 16, No. 8, Oxford University Press.
Girolamo Calo et al., “Pharmacology of Nociceptin and its Receptor: A Novel Therapeutic Target,” British Journal of Pharmacology, 2000, pp. 1261-1283, 129, Macmilian Publishers Ltd.
Daniel Lednicer et al., “4-Amino-4-arylcyclohexanones and Their Derivatives, a Novel Class of Analgesics”, J. Med. Chem., 1980, pp. 424-430, 23.
Ali Ardati et al., “Interaction of [3H]Orphanin FQ and125I-Tyr14-Orphanin FQ with the Orphanin FQ Receptor Kinetics and Modulation by Cations and Guanine Nucleotides,” Molecular Pharmacology, 1997, pp. 816-824, 51, The American Society for Pharmacology and Experimental Therapeutics.
E.G. Gray, et al. “The Isolation of Nerve Endings from Brain: An Electron-Microscopic Study of Cell Fragments Derived By Homogenization and Centrifugation”, Journal of Anatomy, 1962, pp. 79-88, vol. 96, Part 1.
Martin Ch. Frink et al., “Influence of Tramadol of Neurotransmitter Systems of the Rat Brain”, Arzneim-Forsch Drug Res., 1996, pp. 1029-1036, vol. 46 (II), Nr. 11.
Hinze Claudia
Schick Hans
Sundermann Bernd
Crowell & Moring LLP
Gruenenthal GmbH
Powers Fiona T
LandOfFree
Substituted cyclohexylcarboxylic acid amide compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted cyclohexylcarboxylic acid amide compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted cyclohexylcarboxylic acid amide compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3721346